Evidence map›Paper›PMID 36675675›Full record

ArticleJournal of personalized medicine2022

Genetic Predictors of the Development of Complications after Coronary Stenting.

Dana Taizhanova, Akerke Kalimbetova, Roza Bodaubay, Aliya Toleuova, Rakhima Toiynbekova, Zhazira Beysenbekova, Olga Visternichan, Zauresh Tauesheva, Irina Kadyrova, Dmitriy Babenko and 6 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 70% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Dana TaizhanovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Akerke KalimbetovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.ORCID 0000-0003-1550-5469
Roza BodaubayDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Aliya ToleuovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Rakhima ToiynbekovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Zhazira BeysenbekovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Olga VisternichanDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Zauresh TaueshevaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Irina KadyrovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Dmitriy BabenkoDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Lyudmila AkhmaltdinovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Svetlana KolesnichenkoDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.ORCID 0000-0003-3515-8900
Yevgeniya KolesnikovaDepartment of Internal Medicine Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Olga V AvdienkoShared Resource Laboratory, Scientific and Research Center, Karaganda Medical University, Karaganda 100000, Kazakhstan.
Ainur AkilzhanovaNational Laboratory Astana, Laboratory of Genomic and Personalized Medicine, Nazarbayev University, Astana 010000, Kazakhstan.ORCID 0000-0001-6161-8355
Grigorios T GerotziafasCancer Biology and Therapeutics, Centre de Recherche Saint-Antoine, Institut National de la Santé et de la Recherche Médicale, INSERM U938 and Faculté de Médecine Pierre et Marie Curie (UPMC), Sorbonne Universities, 75006 Paris, France.ORCID 0000-0003-2316-6348
Karaganda Medical University · KZInserm · FRNazarbayev University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the fact that there are scientific discussions about the significance of gene polymorphisms in the risk of developing cardiovascular complications after a percutaneous coronary intervention, it is of interest to evaluate the genetic predictors of the development of cardiovascular events. This study is a molecular genetic study. Association with the genes of biomarkers for inflammation and immune response increases the risk of cardiovascular events: rs1234313 (TNFSF4): (A/G, OR-4.57 (2.35-8.87),

Indexed as

complicationcoronary stentinggenetic predictorsrisk factors

Identifiers

PMID36675675
PMCPMC9863814
OpenAlexW4312186753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.